The iconic rise of Viagra has long been a example of pharmaceutical success, but its legacy within the broader industry now raises questions about long-term gains. Alternative versions are diminishing market share, leading to anxieties that supporting companies significantly dependent to Viagra's previous standing could be a problematic decision ,